Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact of Medicare drug price negotiations, ongoing drug shortages, and the promising role of AI and telehealth in improving patient outcomes and access to clinical trials.
The fungus could cause an infection that threatens vision, the FDA said. Customers in California are urged to throw the eye drops away.
Vivek Subbiah: The latest and greatest in cancer research in 2024 / cancer, OncoDaily, Oncology, Vivek Subbiah
Elena Frye Naharro, Michael A. Linden; Auer rod–like inclusions in B-cell lymphoma mimicking therapy-related acute myeloid leukemia. Blood 2024; 144 (26): 2793. doi: https://doi.org/10.1182/blood.2024025759 A…
The OncoAlert Newsletter is now out for June 23-29, 2023
More than half of the cats at the sanctuary in Shelton, Wash., died of the virus over the past several weeks.
The OncoAlert Newsletter is now out for June 23-29, 2023
Several factors informed HTA outcomes for new cancer medicines. A high ESMO-MCBS score, defined as indicating substantial clinical benefit, increased the likelihood of a positive…
The application of artificial intelligence methods to electronic patient records paves the way for large-scale analysis of multimodal data. Such population-wide data describing deep phenotypes…
Why the AQUILA trial is disappointing for patients and their loved ones
